MMP-7 (− 181A > G) promoter polymorphisms and risk for cervical cancer
Introduction
Cervical cancer is the most common cancer among women in many developing countries including India [1]. Age-standardized incidence of 17.2 to 55 per 100,000 has been seen in women from different regions of India [2]. Though cervical cancer is multifactorial in origin, the genetic predisposition also plays an important role [3]. Identification of genetic variants that are associated with cervical cancer will contribute to understanding of underlying mechanisms behind its development and potentially provide therapeutic targets.
MMP-7 (also known as matrilysin or PUMP-1) is a protease with the lowest molecular weight and has broad substrate specificity. It degrades elastin, proteoglycans, fibronectin, and type IV collagen [4], [5], [6]. Over-expression of matrilysin (MMP-7) is predominantly associated with epithelial pre-malignant cells. MMPs are synthesized by stromal cells and produced exclusively by cancer cells, and participate directly in the process of invasion and metastasis, including squamous cell carcinomas of the head, neck and lung and adenocarcinoma of the breast and prostate cancer [7], [8], [9]. The gene encoding MMP-7 is localized on chromosome 11q21–q22. Two polymorphisms exist in the MMP-7 promoter region, − 181A > G and − 153 C > T which are known to modify the gene transcription activity [10], [11]. Numerous studies have shown association of MMP-7 − 181A > G polymorphisms with malignant diseases [12], [13], [14], [15], [16]. However, till date, association of the MMP-7 functional polymorphism − 181A > G with risk of cervical cancer has not been demonstrated. Wu et al. [17] reported that MMP-7 is highly expressed in metastatic cervical squamous cell carcinoma, and may serve as a marker in estimating the invasive and metastatic potential of cervical squamous cell carcinoma. Therefore, we evaluated the association of MMP-7 (181A > G) genetic variation and susceptibility to cervical cancer, its clinical stages and modulation of risk after interaction with tobacco habits.
Section snippets
Subjects
From January 2005 to April 2007, one hundred fifty invasive carcinoma of uterine cervix confirmed by cervical biopsy, were consecutively taken from different gynecology units of Lucknow hospitals. At the same time, one hundred sixty two unrelated cancer-free women, age, ethnicity matched, cervical cytology negative were recruited from routine colposcopy screening clinic belonging to the same institution. Clinical data were obtained by questionnaire, personal interviews and review of case
Results
The mean age (years ± SD) of patients and healthy controls were 47.2 years ± 8.8 and 48.3 years ± 8.3 respectively. Characteristics of cervical cancer patients are shown in Table 1.
Discussion
MMP-7 has tendency to localize in epithelial cells. It has been also shown that MMP-7 is immunolocalized predominantly to the cytoplasm of cervical carcinoma cells, monocytes and normal mucosa [21]. The present study showed that individuals with MMP-7 − 181GG genotypes and − 181G allele were at significant increased risk of cervical cancer (OR 1.94; OR 1.37). Previous studies have found that presence of − 181G variant allele results in higher level of MMP-7 expression [11]. Also, MMP-7 bears
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
Acknowledgments
We gratefully acknowledge the assistance of Dr. Rekha Sachan in sample collection. The study was supported by research grant from UP Council of Science and Technology (UPCST) India.
References (34)
- et al.
Purification and properties of a small latent matrix metalloproteinase of the rat uterus
J Biol Chem
(1988) - et al.
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions
Int J Biochem Cell Biol
(1996) - et al.
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China
Gynecol Oncol
(2006) - et al.
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium
J Invest Dermatol
(1995) - et al.
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma
Brain Res
(2006) - et al.
Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers
Am J Obstet Gynecol
(1988) - et al.
Matrix metalloproteinase-1 and skin ageing in smokers
Lancet
(2001) - et al.
Estimating the world cancer burden: Globocan 2000
Int J Cancer
(2001) - et al.
Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India
Salud Publica de Mexico
(2003) - et al.
The IL-10 -1082G polymorphism is associated with clearance of HPV infection
BJOG
(2006)
Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line
Cancer Res
Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours
Int J Cancer
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Nature
Expression of metalloproteinase genes in human prostate cancer
J Cancer Res Clin Oncol
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival
Clin Cancer Res
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients
Arterioscler Thromb Vasc Biol
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms
Clin Chem
Cited by (33)
A comprehensive meta-analysis of non-coding polymorphisms associated with precancerous lesions and cervical cancer
2022, GenomicsCitation Excerpt :This polymorphism was previously studied in Indian and Chinese populations. Literature evidence suggests that the higher expression of MMP7 can alter the signalling pathways of proliferation, apoptosis and invasion [35–37]. Thus, the presence of a polymorphism in the promoter region of this gene may increase the MMP7 transcript, which is critical for the cell's predisposition to carcinogenic transformations.
Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study
2017, Kaohsiung Journal of Medical SciencesAssociation of MMP7 - 181A → G promoter polymorphism with gastric cancer risk: Influence of nicotine in differential allele-specific transcription via increased phosphorylation of cAMP-response element-binding protein (CREB)
2015, Journal of Biological ChemistryCitation Excerpt :In contrast, in the Caucasian population, the frequency of GG genotype was lower in gastric cancer (28). In the Indian population, the MMP7 −181GG genotype was at a significantly higher risk of cervical cancer (41) and contributed to squamous cell gastric cancer susceptibility in the Kashmir Valley (36). We addressed the effect of promoter variants of MMP7 −181A→G on expression of MMP7 protein.
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview
2013, Mutation Research - Reviews in Mutation ResearchUpdate meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: Evidence from 25 studies
2013, GeneCitation Excerpt :Among them, an A to G transition at the − 181 base pair position (− 181A/G) has been proved to be functional in vitro and may contribute to genetic susceptibility of cancers (Jormsjo et al., 2001). Recently, Many studies indicated that the common MMP-7 (− 181A>G) genetic polymorphism was correlated with cancer risk in many cancer types (Jaboin et al., 2011; Kim et al., 2011; Malik et al., 2011a; Ohtani, 2009; Peng et al., 2010; Qiu et al., 2008; Singh et al., 2008; Srivastava et al., 2010; Yi et al., 2010; Yuan-Yuan et al., 2012). However, this relationship remains controversial.